AH Equity Partners Bio II, L.L.C. 13F Holdings · last filed Q3 2022
AH Equity Partners Bio II, L.L.C. reported 4 securities worth $143.51M in its SEC 13F filing for Q3 2022 (period ended 2022-09-30). Top holdings: EQRX (60.15%), NAUT (24.08%), ERAS (13.59%). Among its top 25 positions this quarter: 1 added.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | EQRX | EQRx, Inc. | $86.3M | 60.15% | 17.4M | Hold |
| 2 | NAUT | Nautilus Biotechnology, Inc. | $34.6M | 24.08% | 16.3M | Hold |
| 3 | ERAS | Erasca, Inc. | $19.5M | 13.59% | 2.5M | Hold |
| 4 | NVTA | InVitae Corporation | $3.1M | 2.19% | 1.3M | Added |
Source: SEC Form 13F filings · as of 2022-09-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR